Pfizer New York

New York, New York 10017

1 studies enrolling now · 11 studies all time

What they study most

Advanced or Metastatic Breast Cancer, Breast Cancer, COVID-19, COVID-19 (Coronavirus Disease 2019), Carcinoma, Renal Cell, Chronic Leukemia Myelogenous, Malignant Neoplasm of Breast, Metastatic Breast Cancer

Studies at this site

• A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML). — Recruiting now
• A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib) — Completed
• A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions. — Completed
• A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib) — Completed
• A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database — Completed
• A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe — Completed
• A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer — Running, not enrolling
• Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. — Completed
• A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions. — Completed
• Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study). — Stopped early
• Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone — Completed